In addition to SEB-specific IgE-sensitization, 57% of patients with atopic dermatitis showed TSST-1-specific IgE antibodies in their serum, indicating a type 2 immune response against this toxin [228]. The gene discussed is IGHE; the disease is atopic eczema.